Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial
scientific article published on 16 October 2017
Author/s
author: David J Moliterno, Kenneth W Mahaffey, Lars Wallentin, Robert A Harrington, Claes Held, Pierluigi Tricoci, Renato Delascio Lopes, Harvey White, Paul W. Armstrong, Philip Aylward, Frans Van de Werf, Sergio Leonardi, Karen P Alexander
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.